SEC Form 4 · accession 0001077183-19-000014
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Bonello
Officer — Chief Strategy Officer
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | M | 40,166 | $8.03 | A | 40,166 | D | |
| Common Stock | Feb 26, 2019 | M | 20,037 | $7.52 | A | 60,203 | D | |
| Common Stock | Feb 26, 2019 | S | 60,203 | $18.90 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $8.03 | Feb 26, 2019 | M | 40,166 | D | Feb 26, 2019 | Feb 26, 2023 | Common Stock | 40,166 | 80,334 | D |
| Stock Option (Right to Buy) | $7.52 | Feb 26, 2019 | M | 20,037 | D | Apr 28, 2018 | Apr 28, 2022 | Common Stock | 20,037 | 79,963 | D |